Thursday, April 25,
2019 11:15AM / NSE
GSK, in line with the restructuring of its supply chain operating model, has selected Fidson Healthcare Plc (“Fidson") as its preferred local contract manufacturing partner to take effect from the third quarter of 2021.
With this development, Fidson Healthcare Plc is poised to increase the capacity utilization of its ultramodern manufacturing facility at Otta, Ogun State and by extension its profitability. Fidson envisages that all necessary regulatory approvals would be obtained to execute the contract successfully.
The selection process which commenced about two years ago ended on Friday, the 12th of April 2019 with a signing ceremony at the Corporate Head Office of GSK Nigeria in Lagos.
About GlaxoSmithKline Consumer Nigeria PLC
An affiliate of GlaxoSmithKline Plc, GlaxoSmithKline Consumer Nigeria PLC (GSK Nigeria) is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information, see www.gsk.com/ng.
About Fidson Healthcare PLC
Fidson Healthcare Plc is a leading pharmaceutical manufacturing company in Nigeria. Founded in 1995, the company is built on the five core values of Innovation, Excellence, Passion, Integrity and Ownership and is relentlessly pursuing its goal of becoming a leading player in the pharmaceutical landscape in Nigeria. www.fidson.com.
Visit Fidson Healthcare Plc IR Page in Proshare MARKETS
Graph 1: Fidson Healthcare Plc – One Year Share Price Movement
Table: Audited 2018 Results